Experiment 1085291
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | SCHULMAN,P: BUDMAN,DR: VINCIGUERRA,V: WEISELBERG,L: ABRAMS,S: DEGNAN,T:. (1982). PHASE II STUDY OF DIVIDED-DOSE VINBLASTINE IN NONSMALL CELL BRONCHOGENIC CARCINOMA.. 66() |
| Amount utilized | |
| Compound isolated | |
| Disease | A PHASE II STUDY IN 22 EVALUABLE CASES OF NON-SMALL CELL BRONCOGENIC CARCINOMA 4 DOSES 6 HOURS APART OVER 2 DAYS EVERY 2 WEEKS. THE FIRST DOSSE WAS TWICE THE NEXT THREE. 27% MAJOR RESPONSE RATE WAS SEEN,WITH A MEDIAN DURATION OF 5.5MONTHS. MAJOR TOXIC EFFECT WAS MYELOSUPPRESSION BUT WAS EASILY MANAGEABLE AND TOLERATED. |
| Dose amount | 1.2 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |